Brendan Mcdonnell serves as Executive at HOLLIS EDEN PHARMACEUTICALS INC /DE/, where they oversee executive responsibilities. Since joining the company, Brendan Mcdonnell has executed 6 insider transactions totaling $125.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 12, 2006 involved purchasing 3,640 shares valued at $20.0K.
Brendan Mcdonnell currently holds 10,000 shares of HOLLIS EDEN PHARMACEUTICALS INC /DE/ (HEPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brendan Mcdonnell has been a net seller of HEPH stock. They have purchased $57.0K and sold $68.5K worth of shares.
Brendan Mcdonnell's most recent insider trade was on Dec 12, 2006, when they purchased 3,640 shares at $5.50 per share.
Get notified when new Form 4 filings are submitted
| $5.82 |
| Discretionary |
| Mar 10, 2006 | HEPH | $11.3K | Option Exercise | 5,000 | $2.25 | Discretionary |
| Mar 10, 2006 | HEPH | $31.4K | Sale | 5,000 | $6.29 | Discretionary |
| Jan 30, 2006 | HEPH | $11.3K | Option Exercise | 5,000 | $2.25 | Discretionary |
| Jan 30, 2006 | HEPH | $37.0K | Sale | 5,000 | $7.41 | Discretionary |